liraglutide and tirzepatide together Semaglutide vs vs Semaglutide & Tirzepatide

The Bottom Line Acid reflux on Mounjaro is a common, usually temporary side effect driven by the medications core mechanism of slowing gastric emptying

Kriwacki R et al

Approval Details: Semaglutide 2.4 mg in MASH On August 15, 2025, the FDA granted accelerated approval of semaglutide 2.4 mg (brand name: Wegovy) for the treatment of noncirrhotic MASH in adults with liver fibrosis stages F2 to F3

More and more Ozempic users are now coming forward with diagnoses of serious stomach symptoms and stomach paralysis, which has been tied to the use of the drug

doi:10.1093/advances/nmy057 de Ligny W, Smits RM, Mackenzie-Proctor R, et al